ATE308497T1 - Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen - Google Patents

Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen

Info

Publication number
ATE308497T1
ATE308497T1 AT97920694T AT97920694T ATE308497T1 AT E308497 T1 ATE308497 T1 AT E308497T1 AT 97920694 T AT97920694 T AT 97920694T AT 97920694 T AT97920694 T AT 97920694T AT E308497 T1 ATE308497 T1 AT E308497T1
Authority
AT
Austria
Prior art keywords
pct
cyclin
interaction
estrogen receptor
trials
Prior art date
Application number
AT97920694T
Other languages
English (en)
Inventor
Rene Bernards
Rob J A M Michalides
Renate M L Zwijsen
Original Assignee
Prolifix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prolifix Ltd filed Critical Prolifix Ltd
Application granted granted Critical
Publication of ATE308497T1 publication Critical patent/ATE308497T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
AT97920694T 1996-04-19 1997-04-16 Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen ATE308497T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9608143.5A GB9608143D0 (en) 1996-04-19 1996-04-19 Assay
PCT/EP1997/001888 WO1997040378A1 (en) 1996-04-19 1997-04-16 Interaction of cyclin d1 and estrogen receptor and its use in assays

Publications (1)

Publication Number Publication Date
ATE308497T1 true ATE308497T1 (de) 2001-11-15

Family

ID=10792355

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920694T ATE308497T1 (de) 1996-04-19 1997-04-16 Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen

Country Status (10)

Country Link
US (1) US6033843A (de)
EP (1) EP0898708B1 (de)
JP (1) JP2000508777A (de)
AT (1) ATE308497T1 (de)
AU (1) AU2698197A (de)
CA (1) CA2249396A1 (de)
DE (1) DE69708081T2 (de)
DK (1) DK0898708T3 (de)
GB (1) GB9608143D0 (de)
WO (1) WO1997040378A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018124A1 (en) * 1997-10-07 1999-04-15 Merck & Co., Inc. Assays for nuclear receptor ligands using fret
AU2533499A (en) 1998-02-12 1999-08-30 Prolifix Limited Interaction between cyclin d1 and steroid receptor co-activators and uses thereof in assays
US6210924B1 (en) * 1998-08-11 2001-04-03 Amgen Inc. Overexpressing cyclin D 1 in a eukaryotic cell line
WO2001059448A1 (fr) * 2000-02-10 2001-08-16 Chugai Seiyaku Kabushiki Kaisha Procede de criblage d'un agent antiandrogene
ATE445164T1 (de) * 2000-06-22 2009-10-15 Univ Paris Descartes Zusammensetzungen und methoden zum nachweis, behandeln oder vorhersagen der antwort von brust tumorzellen auf eine endocrin-therapie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69325383T2 (de) * 1992-10-29 1999-11-25 Medical Research Council, London Testreihenanalyse-Verfahren mit transkriptionsfaktor DP-1

Also Published As

Publication number Publication date
EP0898708A1 (de) 1999-03-03
WO1997040378A1 (en) 1997-10-30
DE69708081T2 (de) 2002-07-04
DE69708081D1 (de) 2001-12-13
DK0898708T3 (da) 2002-03-04
AU2698197A (en) 1997-11-12
GB9608143D0 (en) 1996-06-26
US6033843A (en) 2000-03-07
CA2249396A1 (en) 1997-10-30
EP0898708B1 (de) 2001-11-07
JP2000508777A (ja) 2000-07-11

Similar Documents

Publication Publication Date Title
PT1053256E (pt) Anticorpos para o receptor de morte 4 (dr4) e utilizações destes
IL117425A0 (en) Receptor activation by gas6
TR200200662T2 (tr) Alzheimer hastalığı sekretazı
TR200003513T2 (tr) Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları
AR018023A1 (es) Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada
MY146518A (en) Methods to culture circovirus.
DE60044298D1 (de) Ausflockung von zellmaterial
DK0701604T3 (da) Immortalisering af dendritiske celler med V-myc-onkogenet
DE69708081D1 (de) Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen
ATE262537T1 (de) Proliferationsinhibitor von endothellzellen und dessen verwendung
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
ATE400654T1 (de) Neues säugetiergen bc1-w, welches zur bc1-2 familie apoptose-kontrollierender gene gehört
Thomas Positive and negative regulation of leukocyte activation by protein tyrosine phosphatases
Smadja et al. PAR‐1 activation has different effects on the angiogenic activity of endothelial progenitor cells derived from human adult and cord blood
ATE274351T1 (de) Verwendung von isolierten domänen des type-iv- kollagens zur änderung der zell- und gewebewechselwirkung
DE59508100D1 (de) Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander
Lefor et al. Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model
ATE315091T1 (de) Modifizierte zellen auf der basis des betain- katabolismus, herstellung und verwendung insbesondere zur herstellung von metaboliten oder enzymen
DK1095032T3 (da) Hidtil ukendte fluorescerende CYP2D-assayreagenser
HUP0101393A1 (hu) Redukáló körülményekre érzékeny transzfektáló kompozíciók, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE417926T1 (de) Zusammensetzungen zur modulierung der länge von telomeren
TR200003695T2 (tr) Anjiyostatin bağlayıcı protein.
ATE246335T1 (de) Universelles tarnmaterial für tarnkleidung und zur tarnung
BR0008536A (pt) Usos de um meio de cultura, e de pelo menos um mas, análogo de mas ou um aditivo ou aditivos, e, processo para fertilização in vitro
ATE302273T1 (de) Cadherin derived growth factor und seine verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties